Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase II Study of TRK-820 Soft Capsules — Intractable Pruritus in Patients With Chronic Liver Disease —
This study has been completed.
Study NCT00638495   Information provided by Toray Industries, Inc

First Received on March 12, 2008.   Last Updated on January 28, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Pruritus With Chronic Liver Disease
Additional conditions recognized in this trial
Liver Diseases
Pruritus
More general conditions related to this trial
Digestive System Diseases
Signs and Symptoms
Skin Diseases
Skin Manifestations
Interventions listed in this trial
Nalfurafine Hydrochloride (TRK-820)
Placebo
Sponsors listed in this trial
Toray Industries, Inc


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services